Your browser doesn't support javascript.
loading
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents.
Mina, Roberto; Petrucci, Maria Teresa; Bonello, Francesca; Bongarzoni, Velia; Saccardi, Riccardo; Bertuglia, Giuseppe; Mengarelli, Andrea; Spadaro, Andrea; Lisi, Chiara; Curci, Paola; Lemoli, Roberto Massimo; Ballanti, Stelvio; Floris, Rita; Cupelli, Luca; Tosi, Patrizia; Olivieri, Attilio; Rota-Scalabrini, Delia; Cangialosi, Clotilde; Nozzoli, Chiara; Anaclerico, Barbara; Fazio, Francesca; Bruno, Benedetto; Mancuso, Katia; Corradini, Paolo; Milone, Giuseppe; Boccadoro, Mario.
Afiliação
  • Mina R; Division of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino. roberto.mina@unito.it.
  • Petrucci MT; Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.
  • Bonello F; Medical Oncology Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo.
  • Bongarzoni V; U.O.C. Ematologia, Azienda Ospedaliera "San Giovanni/Addolorata", Roma.
  • Saccardi R; Cellular Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence.
  • Bertuglia G; Division of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino.
  • Mengarelli A; Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome.
  • Spadaro A; Division of Hematology, AOU Policlinico, University of Catania.
  • Lisi C; Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.
  • Curci P; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari.
  • Lemoli RM; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genova, Italy; IRCCS Policlinico San Martino, Genova.
  • Ballanti S; Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, localita Sant'Andrea delle Fratte, Perugia.
  • Floris R; S.C. Ematologia e CTMO, Ospedale Oncologico "A. Businco", Cagliari.
  • Cupelli L; Department of Hematology, S. Eugenio Hospital, Rome.
  • Tosi P; Hematology Unit, Infermi Hospital, Rimini.
  • Olivieri A; Clinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona.
  • Rota-Scalabrini D; Medical Oncology Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo.
  • Cangialosi C; U.O.C. Ematologia, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo.
  • Nozzoli C; Cellular Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence.
  • Anaclerico B; U.O.C. Ematologia, Azienda Ospedaliera "San Giovanni/Addolorata", Roma.
  • Fazio F; Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.
  • Bruno B; Division of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino.
  • Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli", Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Universita di Bologna, Bologna.
  • Corradini P; Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Universita di Milano, Milano.
  • Milone G; Division of Hematology, AOU Policlinico, University of Catania.
  • Boccadoro M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino.
Haematologica ; 2023 Nov 16.
Article em En | MEDLINE | ID: mdl-37981892
ABSTRACT
High-dose melphalan plus autologous stem-cell transplantation (ASCT) is a standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM), and adequate hematopoietic stem-cell (HSC) collection is crucial to ensure hematologic recovery after ASCT. In this prospective, observational study we evaluated HSC mobilization with granulocyte colony-stimulating factor (G-CSF), cyclophosphamide, and 'on-demand' plerixafor (in patients with.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article